Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3911 ARTÍCULOS , VIENDO DEL 631 AL 645

Disorders of the oral cavity in Parkinson's disease and parkinsonian syndromes

Zlotnik Y, Balash Y, Korczyn AD, Giladi N, Gurevich T.

Parkinsons Dis. 2015;2015:379482. doi: 10.1155/2015/379482. Epub 2015 Jan 15.

Neural and nonneural contributions to wrist rigidity in Parkinson's disease: an explorative study using the NeuroFlexor

Zetterberg H, Frykberg GE, Gäverth J, Lindberg PG.

Biomed Res Int. 2015;2015:276182. doi: 10.1155/2015/276182. Epub 2015 Jan 22.

The "gender factor" in wearing-off among patients with Parkinson's disease: a post hoc analysis of DEEP study

Colombo D, Abbruzzese G, Antonini A, Barone P, Bellia G, Franconi F, Simoni L, Attar M, Zagni E, Haggiag S, Stocchi F.

ScientificWorldJournal. 2015;2015:787451. doi: 10.1155/2015/787451. Epub 2015 Jan 20.

Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson disease: a systematic review and meta-analysis

Chou YH, Hickey PT, Sundman M, Song AW, Chen NK.

JAMA Neurol. 2015 Apr;72(4):432-40. doi: 10.1001/jamaneurol.2014.4380.

Parkinson's disease and sleep/wake disturbances

Suzuki K, Miyamoto M, Miyamoto T, Hirata K.

Curr Neurol Neurosci Rep. 2015 Mar;15(3):8. doi: 10.1007/s11910-015-0525-5.

Interferon-γ-induced neurotoxicity of human astrocytes

Hashioka S, McGeer EG, Miyaoka T, Wake R, Horiguchi J, McGeer PL.

CNS Neurol Disord Drug Targets. 2015;14(2):251-6. doi: 10.2174/1871527314666150217122305.

Dietary factors in the etiology of Parkinson's disease

Agim ZS, Cannon JR.

Biomed Res Int. 2015;2015:672838. doi: 10.1155/2015/672838. Epub 2015 Jan 20.

Nizatidine ameliorates slow transit constipation in Parkinson's disease

Sakakibara R, Doi H, Sato M, Hirai S, Masaka T, Kishi M, Tsuyusaki Y, Tateno A, Tateno F, Aiba Y, Ogata T, Suzuki Y.

J Am Geriatr Soc. 2015 Feb;63(2):399-401. doi: 10.1111/jgs.13279.

The subthalamic nucleus, oscillations, and conflict

Zavala B, Zaghloul K, Brown P.

Mov Disord. 2015 Mar;30(3):328-38. doi: 10.1002/mds.26072. Epub 2015 Feb 17.

Gut/brain axis and the microbiota

Mayer EA, Tillisch K, Gupta A.

J Clin Invest. 2015 Mar 2;125(3):926-38. doi: 10.1172/JCI76304. Epub 2015 Feb 17.

Safety and tolerability of intracerebroventricular PDGF-BB in Parkinson's disease patients

Paul G, Zachrisson O, Varrone A, Almqvist P, Jerling M, Lind G, Rehncrona S, Linderoth B, Bjartmarz H, Shafer LL, Coffey R, Svensson M, Mercer KJ, Forsberg A, Halldin C, Svenningsson P, Widner H, Frisén J, Pålhagen S, Haegerstrand A.

J Clin Invest. 2015 Mar 2;125(3):1339-46. doi: 10.1172/JCI79635. Epub 2015 Feb 17.

¹⁸F-FP-(+)-DTBZ positron emission tomography detection of monoaminergic deficient network in patients with carbon monoxide related parkinsonism

Chang CC, Hsiao IT, Huang SH, Lui CC, Yen TC, Chang WN, Huang CW, Hsieh CJ, Chang YY, Lin KJ.

Eur J Neurol. 2015 May;22(5):845-52, e59-60. doi: 10.1111/ene.12672. Epub 2015 Feb 18.

Prodromal dementia with Lewy bodies

Fujishiro H, Nakamura S, Sato K, Iseki E.

Geriatr Gerontol Int. 2015 Jul;15(7):817-26. doi: 10.1111/ggi.12466. Epub 2015 Feb 17.

Compromised MAPK signaling in human diseases: an update

Kim EK, Choi EJ.

Arch Toxicol. 2015 Jun;89(6):867-82. doi: 10.1007/s00204-015-1472-2. Epub 2015 Feb 18.

Fluctuating Cotard syndrome in a patient with advanced Parkinson disease

Solla P, Cannas A, Orofino G, Marrosu F.

Neurologist. 2015 Feb;19(3):70-2. doi: 10.1097/NRL.0000000000000010.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias